In recent years, the familiar symptoms of the flu might kick us into reaching for at-home testing kits. But on the eve of the ...

CERo’s technology works by grafting onto patients’ own T-cells a receptor that binds to a naturally occurring human antigen that is upregulated in cancer cells.

New research led by Yale School of Medicine (YSM) advances the goals of creating a diagnostic test and vaccines for ...

Equities researchers at HC Wainwright issued their FY2025 earnings per share estimates for shares of Virax Biolabs Group in a research note issued to investors on Monday, March 31st. HC Wainwright ...

A new business in Lower Paxton Township is looking to help treat men’s health issues. Gameday Men’s Health might sound like ...

Research analysts at Chardan Capital issued their FY2025 earnings per share (EPS) estimates for CARGO Therapeutics in a note ...

Hematologist-oncologist Mateo Mejia Saldarriaga, MD, combines clinical care with research aimed at helping patients with ...

Helix BioPharma is a clinical-stage biopharmaceutical company aiming to turn scientific breakthroughs into real-world solutions for some of the most difficult-to-treat cancers.

Until now, little was known about the mechanisms behind these changes in antigen expression. This gap in our knowledge has been filled by the study led by Colomé-Tatché and Siegel, which has ...

Janux Therapeutics' lead drug, JANX007, shows promising prostate cancer results with no serious side effects. Find out why ...

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative ...